---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-26-000020"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:38:59.819247+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Systems provides historical revenue by new product categories for 2022-2025

## Summary
- Total revenue grew from $1.151B in 2022 to $1.516B in 2025, with foundational revenue at $1.029B and therapeutic at $487M in 2025.
- Therapeutic revenue increased 24% year-over-year in 2025, driven by cardiac therapies ($93.4M), endoscopy ($72.5M), and oncology ($96.8M).
- Foundational revenue rose to $1.029B in 2025 from $862M in 2022, with access ($588.5M) and OEM ($167.1M) as top platforms.
- Quarterly total revenue rose sequentially from $355M in Q1 2025 to $394M in Q4 2025, with therapeutic platform growing each quarter.

## SEC filing metadata
- accession: 0000856982-26-000020
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698226000020/0000856982-26-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698226000020/mmsi-20260413x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-26-000020
- JSON: https://secwatch.observer/filing/0000856982-26-000020.json
- Plain text: https://secwatch.observer/filing/0000856982-26-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.